Quick Answer
Bausch Health Companies Inc. reported Diluted EPS of $0.42 per share for fiscal year 2025.
Bausch Health Companies Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.42 | +423.1% |
| 2024 | -$0.13 | +92.0% |
| 2023 | -$1.62 | -161.3% |
| 2022 | -$0.62 | +76.5% |
| 2021 | -$2.64 | -67.1% |
| 2020 | -$1.58 | +68.9% |
| 2019 | -$5.08 | +57.0% |
| 2018 | -$11.81 | -272.9% |
| 2017 | $6.83 | +198.4% |
| 2016 | -$6.94 | -716.5% |
| 2015 | -$0.85 | -132.9% |
| 2014 | $2.58 | +195.6% |
| 2013 | -$2.70 | -610.5% |
| 2012 | -$0.38 | -177.6% |
| 2011 | $0.49 | +146.2% |
| 2010 | -$1.06 | -195.5% |
| 2009 | $1.11 | -11.2% |
| 2008 | $1.25 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.48 | +308.7% | +20.0% |
| June 30, 2025 | $0.40 | +1233.3% | +350.0% |
| March 31, 2025 | -$0.16 | +5.9% | +30.4% |
| September 30, 2024 | -$0.23 | +77.7% | -866.7% |
| June 30, 2024 | $0.03 | -57.1% | +117.6% |
| March 31, 2024 | -$0.17 | +69.1% | +83.5% |
| September 30, 2023 | -$1.03 | -193.6% | -1571.4% |
| June 30, 2023 | $0.07 | +117.5% | +112.7% |
- Bausch Health Companies Inc. showed an increase of +423.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, Bausch Health Companies Inc.’s diluted eps has declined by 66.4% (from $1.25 per share to $0.42 per share).
- The most recent figure is from Bausch Health Companies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: